Image from Google Jackets

Profile of the Philippine pharmaceutical sector / Celia M. Reyes [and four others]

Contributor(s): Series: DISCUSSION PAPER SERIES ; NO. 2011-11Description: 72 pages : tables, graphsContent type:
  • text
Media type:
  • unmediated
Carrier type:
  • volume
Subject(s): Online resources: Abstract: The Philippines is one of the biggest pharmaceutical markets in the ASEAN region, next only to Indonesia and Thailand.1 It is a lifeline to thousands of Filipino workers and a significant contributor in terms of value of output. This industry is one of the fastest growing industries in the country. Meanwhile, its output, drugs and medicines, account for 46 percent of the total medical out-of-pocket expenses of Philippine households. For poorer people, this percentage goes up to 55 percent.2 Making essential drugs and medicines more affordable especially to the poor and underserved is one of the Millennium Development Goals (MDGs). It is therefore essential to examine the profile of the pharmaceutical industry in the country to better understand the supply chain of drugs and medicines for policy formulation purposes. Using administrative data from agencies that have regulative powers over the industry, a profile of the Philippine pharmaceutical industry was developed. As of December 2009, the Food and Drug Administration’s records show that there are 284 drug manufacturers, 438 drug traders, 634 drug importers, 4,719 drug distributors of which 3,956 are wholesalers, and 32,538 retail outlets. Manufacturing is dominated by multi-national brand originator giants and numerous local generics/branded generics producers. Meanwhile, trading is done by few large companies and thousands of small retail outlets. The industry players are diverse and formulating policies therefore must take into consideration how each player may be affected by policy issuances.
Hello from Record Display Customizations!
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)

The Philippines is one of the biggest pharmaceutical markets in the ASEAN region, next only to
Indonesia and Thailand.1
It is a lifeline to thousands of Filipino workers and a significant
contributor in terms of value of output. This industry is one of the fastest growing industries in
the country. Meanwhile, its output, drugs and medicines, account for 46 percent of the total
medical out-of-pocket expenses of Philippine households. For poorer people, this percentage
goes up to 55 percent.2
Making essential drugs and medicines more affordable especially to the
poor and underserved is one of the Millennium Development Goals (MDGs). It is therefore
essential to examine the profile of the pharmaceutical industry in the country to better understand
the supply chain of drugs and medicines for policy formulation purposes. Using administrative
data from agencies that have regulative powers over the industry, a profile of the Philippine
pharmaceutical industry was developed. As of December 2009, the Food and Drug
Administration’s records show that there are 284 drug manufacturers, 438 drug traders, 634 drug
importers, 4,719 drug distributors of which 3,956 are wholesalers, and 32,538 retail outlets.
Manufacturing is dominated by multi-national brand originator giants and numerous local
generics/branded generics producers. Meanwhile, trading is done by few large companies and
thousands of small retail outlets. The industry players are diverse and formulating policies
therefore must take into consideration how each player may be affected by policy issuances.

There are no comments on this title.

to post a comment.
Previous
Back to results
Next
Close